文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals.

作者信息

Goletti Delia, Meintjes Graeme, Andrade Bruno B, Zumla Alimuddin, Shan Lee Shui

机构信息

Translational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani"- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.

Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

出版信息

Int J Infect Dis. 2025 Jan;150:107325. doi: 10.1016/j.ijid.2024.107325. Epub 2024 Dec 2.

DOI:10.1016/j.ijid.2024.107325
PMID:39631498
Abstract
摘要

相似文献

[1]
Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals.

Int J Infect Dis. 2025-1

[2]
[Expert consensus on tuberculosis preventive treatment for individuals at high risk of developing active diseases from latent tuberculosis infection in comprehensive medical facilities].

Zhonghua Jie He He Hu Xi Za Zhi. 2024-10-12

[3]
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet Infect Dis. 2024-7

[4]
Depression among people living with tuberculosis and tuberculosis/HIV coinfection in Ukraine: a cross-sectional study.

Glob Health Action. 2025-12

[5]
Ending tuberculosis by 2030: can we do it?

Int J Tuberc Lung Dis. 2016-9

[6]
Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets - 2017.

MMWR Morb Mortal Wkly Rep. 2019-3-22

[7]
Global Epidemiology of Tuberculosis.

Semin Respir Crit Care Med. 2018-8-2

[8]
Prevalence, treatment outcomes and determinants of TB/HIV coinfection: A 4-year retrospective review of national tuberculosis registry in a country in a MENA region.

Heliyon. 2024-2-17

[9]
[Access barriers to comprehensive care for people affected by tuberculosis and human immunodeficiency virus coinfection in Peru, 2010-2015].

Rev Panam Salud Publica. 2017-5-25

[10]
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality.

Bull World Health Organ. 2011-5-31

引用本文的文献

[1]
Diagnostic Accuracy of AdvanSure and PowerChek Real-Time PCR Assays for the Detection of and Nontuberculous Mycobacteria.

Diagnostics (Basel). 2025-7-14

[2]
The effects of decentralisation on patient and service outcomes: a case of the 2018 decentralisation of multidrug-resistant tuberculosis in Zambia.

Arch Public Health. 2025-7-24

[3]
Thyroid tuberculosis misdiagnosed as papillary thyroid carcinoma under ultrasound-guided fine-needle aspiration cytology: a case report and literature review.

Gland Surg. 2025-6-30

[4]
Dynamic of infectious aerosols generated by cough from patients with pulmonary tuberculosis.

J Aerosol Sci. 2025-9

[5]
Exploring tuberculosis patients' preferences for AI-assisted remote health management services in China: a protocol for a discrete choice experiment.

BMJ Open. 2025-7-7

[6]
Incidence and Clinical Characteristics of Active Tuberculosis in Psoriasis Patients From a High-Burden Setting: An 18-Year Retrospective Study of 86 Patients.

Exp Dermatol. 2025-7

[7]
Effectiveness of Digital Health Interventions to Enhance Continuity of Care in Patients with Pulmonary Tuberculosis: A Systematic Review of Randomized Controlled Trials.

Patient Prefer Adherence. 2025-6-23

[8]
The Identification of Novel Mutations in ATP-Dependent Protease ClpC1 Assists in the Molecular Diagnosis of Obscured Pyrazinamide-Resistant Tuberculosis Clinical Isolates.

Microorganisms. 2025-6-16

[9]
Immunomodulatory activity of 4-(Benzyloxy)phenol facilitates intracellular mycobacterial clearance through p53 mediated IL-35 signaling dependent JAK1/STAT3 pathway in human macrophages.

Immunol Res. 2025-6-26

[10]
Tuberculosis and Impact of COVID-19 on Spread of Epidemics in Kazakhstan.

Pathogens. 2025-6-4

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索